Garvey’s career spans decades of influential work, shaping national guidelines for obesity and diabetes treatment.

The commission recommends a shift away from relying solely on BMI to more accurately define obesity as a disease.

A UAB expert explains what a certified diabetes and education specialist is and how they can benefit patients with diabetes.

A cluster analysis in the Deep South showed that racial background significantly influences diabetes subtype distribution.

The novel drug TIX100 functions differently from any approved diabetes drug to promote proper islet cell function.

UAB researchers say the presented data indicates that a younger age and higher HbA1c at baseline predict early treatment failure and point to the need for more aggressive initial treatment in these patients.

A healthy lifestyle is about small changes over time that build upon each other.

Lund is the fifth Distinguished Fellow from UAB named since 2019, a sign of the strength of immunology research at UAB.

Vaccination of neonatal mice with group A Streptococcus promotes clonal expansion of B cells that produce antibody against GlcNAc. The association of reduced Type 1 diabetes risk after group A Streptococcus infection is dependent on these GlcNAc-specific B cells.

UAB diabetes expert serves up tailgating hacks to make football season fun and diabetes-friendly.

These results add an additional, mechanistic aspect to further explain how the decades-old blood pressure medication verapamil can preserve beta cell function in Type 1 diabetes patients by affecting the hormone insulin-like growth factor 1.

Continuous glucose monitors can transform one’s diabetes treatment and care. A UAB diabetes expert explains what patients should know about the devices when evaluating their diabetes care plans.

The clinical trial focused on very young children, who have a more rapid loss of the pancreatic beta cells than do adolescents. The trial was constrained to a low-dose level, but showed safety and tolerability and reduced serum glucagon, a secondary outcome.

Diabetic retinopathy is the leading cause of blindness in American adults. The source of this damage may lie in the belly — mainly a leaky small intestine. A novel treatment can possibly prevent or reverse this damage.

This study will enroll patients to evaluate which combination of three proposed interventions — including health coaching, food delivery and remote patient monitoring — will help patients manage diabetes and also be sustainable for health systems to implement.

Given the rising rates of obesity and diabetes, semaglutide could be used effectively to reduce the burden of these chronic diseases.

Knockout of TXNIP improves diabetes-associated hyperglycemia and hyperglucagonemia.

Published results suggest the COVID-19 pandemic exacerbated the slow increase in pediatric Type 2 diabetes.

The Council on Basic Cardiovascular Sciences, known as the BCVS, is one of the largest councils at the American Heart Association, and it is one of the largest organizations in cardiovascular sciences globally, with more than 4,700 members.

This therapy, using sustained release of nitric oxide, may be a novel, efficient and safe way to prevent and treat multiple metabolic diseases.